Stacy Enxing Seng

Stacy Enxing Seng has worked for various companies since 2014, beginning with Solace Therapeutics where they held the role of Director. Stacy then moved to Hill-Rom in 2015, where they were an Independent Director. In 2016, they became a Venture Partner at Lightstone Ventures. In 2017, they became an Independent Director at the Fogarty Institute for Innovation. In 2018, they became an Independent Director at Precardia, Inc. In 2019, they held multiple roles, including Independent Director at LivaNova, Chairwoman of the Board and Independent Director at Cala Health, and Chairwoman of the Board and Independent Director at Contego Medical, Inc. Most recently, in 2021, they became an Independent Director at Vesper Medical, Inc.

Stacy Enxing Seng obtained a Bachelor's Degree in Public Policy Analysis from Michigan State University between 1982 and 1986. Stacy then went on to Harvard Business School where they obtained a Master of Business Administration (M.B.A.) between 1991 and 1993. In 2016, they completed a Certificate of Completion from Stanford University Graduate School of Business in the field of Director's Consortium.